Loading

DEA

  • by Paul Armentano, NORML Deputy Director January 12, 2012

    In December I blogged about rumors that the Obama Justice Department was finalizing plans to expand its recent crackdown on medical cannabis producers and providers to include state-licensed facilities in Colorado. Today, the federal government made good on its threats.

    According to numerous media reports, federal authorities today issued warning letters to 23 state-licensed dispensaries in Colorado stating that “action will be taken to seize and forfeit their property” if they continue operating within 1,000 feet of a school. The letters, sent by U.S. Attorney John Walsh, say that the dispensaries have 45 days from today to close shop or face federal sanction.

    It states, in part:

    “Federal law prohibits the manufacture, distribution, and possession of marijuana. … (This) dispensary is operating in violation of federal law, and the department of Justice has the authority to enforce federal law even when such activities may be permitted under state law. Persons … who operate or facilitate the operation of such dispensaries are subject to criminal prosecution and civil enforcement actions under federal law. Moreover, because the dispensary is operating within 1,000 feet of a school, enhanced federal penalties apply.

    … This letter … constitutes formal notice that action will be taken to seize and forfeit (your) property if you do not cause the sale and/or distribution of marijuana and marijuana-infused substances at (this) location to be discontinued.”

    While the federal government in recent months has utilized similar tactics to close down cannabis providers in California and has also coordinated DEA-led raids of dispensaries in other states, most notably in Washington and Montana, today’s efforts mark the first time that the federal authorities have specifically targeted facilities that are operating explicitly under a state license. (To date, only officials in the states of Colorado, Maine, and New Mexico have formally issued licenses to authorized cannabis providers.) It is estimated that that some 700 state licensed dispensaries are presently operating in Colorado.

    Once again, the federal government’s actions belie the administration’s claim that it only intends to target those medical cannabis operators that “use marijuana in a way that’s not consistent with the state statute.” In this case, the operations in question were grandfathered in under local or state regulations. They are acting in compliance with state law and explicitly with the state’s permission.

    Nonetheless, the imprimatur of the state apparently carries little if any weight with the Obama administration, whose first priority in Colorado appears to be matters of zoning enforcement.

    Legislating medical marijuana operations and prosecuting those who act in a manner that is inconsistent with state law and voters’ sentiment should be a responsibility left to the state and local officials, not the federal government. It is time for this administration to fulfill the assurances it gave to the medical cannabis community and to respect the decisions of voters and lawmakers in states that recognize its therapeutic efficacy.

  • by Paul Armentano, NORML Deputy Director December 14, 2011

    In recent months, the federal Justice Department has engaged in concerted efforts to crack down on the proliferation of medical cannabis related activities in states that allow for its therapeutic use under state law, including California, Montana, and Washington.

    Now, according to a CBS News report, the next state on the federal government’s ‘hit list’ is Colorado — arguably the state with the most comprehensive and stringent statewide regulations governing medical cannabis activities. These regulations explicitly license state-authorized cannabis dispensaries, of which there are now some 700 operating statewide.

    Nonetheless, the imprimatur of the state apparently carries little if any weight with the Obama administration at this time — despite promises (reiterated before Congress just last week by US Attorney General Eric Holder) that such prosecutions are “not a (federal) priority” and that the Justice Department only intends to target those entities who “use marijuana in a way that’s not consistent with the state statute.”

    Predictably, today’s CBS special report tells a different story.

    Crackdown On Colorado’s Medical Pot Business On The Horizon
    via CBS News Denver

    Federal authorities are planning to crack down on the medical marijuana business in Colorado on a large scale for the first time.

    Warning letters will be going out to dispensaries and grow facilities near schools, CBS4 investigator Rick Sallinger has learned. So far it’s not clear how soon that will happen.

    Dispensaries that receive the letters will be given 45 days to shut down or move operations. If they don’t comply, they will be shut down by the U.S. attorney in Colorado.

    The dispensaries who are set to be targeted are the ones that are located within 1,000 feet of schools. That measurement is being used because that distance already appears in federal law as a factor in drug crime sentencing.

    The move comes after the Justice Department sent out a memo clarifying that marijuana has been and remains illegal under federal law despite what has taken place with state regulations. Colorado is one of 16 states where medical marijuana laws have been approved.

    Many of the state’s dispensaries that are closer than 1,000 feet to a school have already been approved to be there under local laws. They usually have been grandfathered in.

    … Robert Corry, an attorney who represents dispensaries, said medical marijuana operations are now strictly regulated under Colorado state laws.

    “The federal apparatus here has better things to do,” said Corry. “My reaction would be the federal government is essentially declaring war on the voters of our state (who) passed a Constitutional amendment.”

    U.S. attorneys in California recently announced in a separate medical marijuana crackdown that they would be targeting landlords who rent retail space to dispensaries, as well as dispensary owners themselves.

    Does anyone really believe that this is an appropriate use of scarce federal resources? Or that these actions are in any way consistent with Obama’s public pledge to cease utilizing “Justice Department resources to try and circumvent state laws on this issue?” I didn’t think so.

    If the federal government is truly concerned about the diversion of
    medical marijuana or its potential abuse in states that have authorized it then it would be better served to encourage — rather than to discourage — statewide and local efforts to regulate these actions accordingly. The Obama administration’s enforcement actions in California, Colorado, and elsewhere will only result in limiting adults’ regulated, safe access to cannabis therapy. It will also cost local jobs and needed tax revenue, and likely result in hundreds — if not thousands — of unnecessary criminal prosecutions.

    Legislating medical marijuana operations and prosecuting those who act in a manner that is inconsistent with state law and voters’ sentiment should be a responsibility left to the state and local officials, not the federal government. It is time for this administration to fulfill the assurances it gave to the medical cannabis community and to respect the decisions of voters and lawmakers in states that recognize its therapeutic efficacy.

  • by Allen St. Pierre, NORML Executive Director November 30, 2011

    The governors of Rhode Island and Washington have both signed a petition asking the Obama Administration to re-schedule cannabis from Schedule I to Schedule II, effectively ending the federal government’s total prohibition on medical patients having lawful and controlled access to organic cannabis products.

    “The situation has become untenable for our states and others. The solution lies with the federal government.”

    Both Governors Lincoln Chafee and Christine Gregoire of Rhode Island and Washington respectively were, ironically, two state governors who chose to heed to the warnings issued by the federal government in a Department of Justice memo (known as the ‘Cole memo‘) and not move forward with otherwise popular medical cannabis law reforms in their states. 

    However, no more! These two governors’ action today is a very important turning point in the history of cannabis law reform in America.

    Contrastingly, the governors of Colorado, Maine, New Jersey, New Mexico and the city council of D.C. all largely ignored the federal government and moved forward with their states’ respective medical cannabis programs.

    NORML began the entire legal and political debate about ‘medical marijuana’ in 1972 when it launched a 24-year re-scheduling effort, that is still laboring on all these years.

    Therefore to finally witness governors so frustrated with the absurdly mis-scheduled cannabis plant as being dangerous, addictive and possessing no medical utility (wrongly grouped with heroin and LSD) that they are reaching out to the president to fix this clear injustice and warping of science is a clear demonstration that the friction between the federal government’s recalcitrance on accepting medical cannabis (or for that matter ending Cannabis Prohibition in total) and state politicians who can no longer justify towing the fed’s ridiculous ban on physician-prescribed cannabis to sick, dying and sense-threatened medical patients is coming to a dramatic conclusion in a government showdown, one that may bode well for the larger Cannabis Prohibition reforms needed, festering just below the surface of the public’s mass acceptance of medical access to cannabis.

  • by Allen St. Pierre, NORML Executive Director October 4, 2011

    In 1972 NORML filed the first major lawsuit against the Drug Enforcement Administration (DEA) to change the legal status of cannabis from schedule I to schedule II. Would this make cannabis legal for an adult to purchase and use like alcohol and tobacco products?

    No.

    All the organization was seeking was an acknowledgement that cannabis had been badly mis-scheduled as a dangerous and highly addictive drug with no accepted medical value. The organization argued in one of the longest (and strangest) legal cases in US history, NORML vs. DEA (1972-1994), that cannabis is a safe, non-toxic herbal medicine that should be within the ambit of choices for a physician to recommend to a sick, dying or sense-threatened medical patient.

    In the late 1990s a coalition of cannabis reform groups refiled a petition to reschedule, which was rejected this past summer by the DEA (see below).

    Please review and sign a new petition asking President Obama to once and for all listen to the many numerous DEA administrative law judges that have previously ruled in the reformers’ favor and all of the clear science published that cannabis is in fact a medicinal product of great worth, providing maximum safety with minimal unwanted side effects and at relatively little cost for the consumer.

    “Nearly all medicines have toxic, potentially lethal effects. But marijuana is not such a substance. There is no record in the extensive medical literature describing a proven, documented cannabis-induced fatality…Simply stated, researchers have been unable to give animals enough marijuana to induce death…In practical terms, marijuana cannot induce a lethal response as a result of drug-related toxicity…In strict medical terms marijuana is far safer than many foods we commonly consume…Marijuana, in its natural form, is one of the safest therapeutically active substances known to man.” – DEA administrative law judge, Francis Young, NORML vs. DEA (1988)

    About 3,000 more signatures are needed by October 23 to meet the necessary threshold. I’ve been told that the White House may raise the threshold soon to qualify petitions for Presidential review from 5,000 to 25,000. Undeterred-in-the-slightest, I’m totally confident that the NORML community will generate in excess of 25,000 signatures in support for this important and long-suffering cannabis re-scheduling for medical purposes.

    Please sign the cannabis rescheduling petition here.

    Medical Marijuana Advocates Sue Federal Government Over Rescheduling Delay
    MONDAY, 23 MAY 2011 11:34

    WASHINGTON–(ENEWSPF)–May 23 – A Coalition of advocacy groups and patients filed suit in the DC Circuit Court today to compel the Obama administration to answer a 9-year-old petition to reclassify medical marijuana. The Coalition for Rescheduling Cannabis (CRC) has never received an answer to its 2002 petition, despite a formal recommendation in 2006 from the Department of Health and Human Services (HHS) to the Drug Enforcement Administration (DEA), the final arbiter in the rescheduling process. As recently as July 2010, the DEA issued a 54-page “Position on Marijuana,” but failed to even mention the pending CRC petition. Plaintiffs in the case include the CRC, Americans for Safe Access (ASA), Patients Out of Time, as well as individually named patients, one of whom is listed on the CRC petition but died in 2005.

    “The federal government’s strategy has been delay, delay, delay,” said Joe Elford, Chief Counsel of ASA and lead counsel on the writ. “It is far past time for the government to answer our rescheduling petition, but unfortunately we’ve been forced to go to court in order to get resolution.” The writ of mandamus filed today accuses the government of unreasonable delay in violation of the Administrative Procedures Act. A previous cannabis (marijuana) rescheduling petition filed in 1972 went unanswered for 22 years before being denied.

    The writ argues that cannabis is not a dangerous drug and that ample evidence of its therapeutic value exists based on scientific studies in the US and around the world. “Despite numerous peer-reviewed scientific studies establishing that marijuana is effective” in treating numerous medical conditions, the government “continues to deprive seriously ill persons of this needed, and often life-saving therapy by maintaining marijuana as a Schedule I substance.” The writ calls out the government for unlawfully failing to answer the petition despite an Inter-Agency Advisory issued by the Food and Drug Administration in 2006 and “almost five years after receiving a 41-page memorandum from HHS stating its scientific evaluation and recommendations.”

    The two largest physician groups in the country — the American Medical Association and the American College of Physicians — have both called on the federal government to review marijuana’s status as a Schedule I substance with no accepted medical use and a high potential for abuse. The National Cancer Institute, a part of the National Institutes of Health, added cannabis to its website earlier this year as a Complementary Alternative Medicine (CAM) and recognized that, “Cannabis has been used for medicinal purposes for thousands of years prior to its current status as an illegal substance.”

    Medical marijuana has now been decriminalized in 16 states and the District of Columbia, and has an 80% approval rating among Americans according to several polls. In a 1988 ruling on a prior rescheduling petition, the DEA’s own Administrative Law Judge Francis Young recommended in favor of reclassification stating that, “Marijuana, in its natural form, is one of the safest therapeutically active substances known to man.”

    A formal rejection of the CRC petition would enable the group to challenge in court the government’s assertion that marijuana has no medical value. “Adhering to outdated public policy that ignores science has created a war zone for doctors and their patients who are seeking use cannabis therapeutics,” said Steph Sherer, Executive Director of ASA and a plaintiff in the writ. Jon Gettman, who filed the rescheduling petition on behalf of the CRC added that, “The Obama Administration’s refusal to act on this petition is an irresponsible stalling tactic.”

    A synthetic form of THC, the main chemical ingredient in the cannabis plant, is currently classified Schedule III for its use in a prescribed pill trademarked as Marinol®. The pill goes off-patent this year and companies vying to sell generic versions are petitioning the government to also reclassify the more economical, naturally-derived THC (from the plant) to Schedule III. The rescheduling process involves federal agencies such as the National Institute on Drug Abuse, HHS, and DEA. On average, it takes 6 months from HHS review to final action, whereas it’s been nearly 5 years since HHS issued its recommendation on the CRC petition, more than twice as long as any other rescheduling petition reviewed since 2002.

    Further information:
    CRC rescheduling petition
    2006 HHS recommendation
    2010 DEA Position on Marijuana

    Writ filed today
    Backgrounder on rescheduling

  • by Erik Altieri, NORML Communications Coordinator September 1, 2011

    This Week in WeedNow streaming on NORMLtv is the latest edition of “This Week in Weed.” This new weekly video series covers the most newsworthy stories shaping the marijuana law reform world. This week a new study is released on cannabis use and obesity, Arkansas lowers marijuana penalties, and the DEA continues to reject proposals to grow cannabis for research purposes.

    Be sure to tune in to NORMLtv each Thursday afternoon to catch up on the latest marijuana news. Subscribe to NORMLtv or follow us on Twitter to get notified as soon as new content is added.

Page 1 of 1012345...10...Last »